Novo Nordisk (NVO) CEO Maziar Mike Doustdar is calling workers back to the office as the Ozempic maker struggles to catch up with Eli Lilly (LLY) in the obesity market, Bloomberg’s Naomi Kresge reports. Office-based employees will need to come in five days a week starting January 1, 2026. The move just says after Doustdar announced the drugmaker would reduce its workforce by 9,000 positions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Novo Nordisk (NVO) Issues Return-to-Office Mandate After Mass Layoffs
- Hold Rating for Novo Nordisk Amid Restructuring and Market Challenges
- Oracle surges on cloud outlook, Novo to cut 9,000 jobs: Morning Buzz
- Another Novo Nordisk profit warning ‘still possible,’ says BofA